Appeal No. 2004-0600 Paper 16
Application No. 10/024,983 Page 4
8. The composition of claim 8/7 contains a water soluble or oil soluble active
ingredient in either the discontinuous aqueous phase or the continuous oil phase,
respectively.
9. The composition of claim 9/8/7 limits the active ingredient to one selected from
vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, biotin, pantothenic acid,
vitamin E, tocopherol, "-tocopherol, ß-tocopherol, (-tocopherol, )-tocopherol,
tocophersolan, tocopheryl acetate, tocopheryl palmitate, tocopheryl linoleate, tocopheryl
nicotinate, tocopheryl succinate, and mixtures thereof.
10. The composition of claim 10/7 comprises a continuous oil phase having 0.2-3.0
wt.% linear silicone polyether, 0.2-10 wt.% ",T-diene crosslinked silicone elastomer,
and 0.1-4.0 wt.% nonionic organic emulsifier, the balance of the W/O emulsion
containing a solvent and water.
11. The composition of claim 11/10/7 limits the solvent to a volatile cyclic alkyl
siloxane with the formula (R'"2SiO)d or a volatile linear alkyl siloxane with the formula
R"'3SiO(R"'2SiO)eSiR"'3 in which R"' is an alkyl group containing 1-6 carbon atoms, d is
3-6 and e is 0-5.
12. More specifically, the composition of claim 12/11/10/7 limits the solvent to
hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, decamethylcyclo-
pentasiloxane, dedecamethylcyclohexasiloxane, hexamethyldisiloxane,
octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane,
tetradecamethylhexasiloxane and hexadecamethylheptasiloxane.
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007